A large-scale genome-wide association study meta-analysis of cannabis use disorder

Medicine & Life Sciences

• Cannabis 100%
• Genome-Wide Association Study 98%
• Meta-Analysis 70%
• Biomedical Research 20%
• Psychopathology 19%
• Organized Financing 15%
• National Institutes of Health (U.S.) 13%
• New Zealand 13%
• Genomics 13%
• National Institute on Deafness and Other Communication Disorders (U.S.) 13%
• National Institute of Biomedical Imaging and Bioengineering (U.S.) 13%
• National Institute of General Medical Sciences (U.S.) 12%
• Tobacco 12%
• Substance-Related Disorders 11%
• National Institute on Alcohol Abuse and Alcoholism (U.S.) 11%
• Health Services Misuse 11%
• Single Nucleotide Polymorphism 11%
• Health Services Administration 11%
• National Institute on Drug Abuse (U.S.) 11%
• National Institute on Aging (U.S.) 10%
• National Institute of Child Health and Human Development (U.S.) 10%
• National Institute of Neurological Disorders and Stroke (U.S.) 9%
• Health 9%
• National Institute of Mental Health (U.S.) 9%
• National Heart, Lung, and Blood Institute (U.S.) 9%
• Chromosomes, Human, Pair 8 9%
• Odds Ratio 8%
• Chromosomes, Human, Pair 7 8%
• United States Department of Veterans Affairs 8%
• Borderline Personality Disorder 8%
• Genetic Loci 8%
• National Cancer Institute (U.S.) 7%
• Linkage Disequilibrium 7%
• Pharmacogenetics 7%
• Mental Health Services 7%
• Precision Medicine 7%
• Child Health 6%
• Schizophrenia 5%
• Mental Disorders 5%
• Psychiatry 4%
• Research Personnel 4%
• Genome 4%
• Depression 4%
• Education 4%
• Brain 3%
• Genes 2%